Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy
Jacobi Hines, Alec Kacew, Randy F. Sweis
Current Oncology Reports (2023) Vol. 25, Iss. 3, pp. 189-199
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The balance of STING signaling orchestrates immunity in cancer
Klara Rasmussen Bollerup Lanng, Emil Leth Lauridsen, Martin R. Jakobsen
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1144-1157
Closed Access | Times Cited: 37
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Xi Chen, Zhijie Xu, Tongfei Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong‐Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 31
Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy
Dinh Chuong Nguyen, Kefan Song, Simbarashe Jokonya, et al.
ACS Central Science (2024) Vol. 10, Iss. 3, pp. 666-675
Open Access | Times Cited: 13
Therapeutic synthetic and natural materials for immunoengineering
Anna Slezak, Kevin Chang, Samir Hossainy, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 1789-1822
Open Access | Times Cited: 11
Delivery of STING agonists for cancer immunotherapy
Jianping Wang, Fanfei Meng, Yoon Yeo
Current Opinion in Biotechnology (2024) Vol. 87, pp. 103105-103105
Closed Access | Times Cited: 9
Laminaran potentiates cGAS-STING signaling to enhance antiviral responses
Lingxiao Xu, Jiao Lyu, Zuo-Cheng Qiu, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114014-114014
Closed Access | Times Cited: 1
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
Dongquan Xiang, Xin-Li Han, Jianxiong Li, et al.
Materials Today Bio (2023) Vol. 20, pp. 100675-100675
Open Access | Times Cited: 21
cGAS-STING signaling pathway in intestinal homeostasis and diseases
Yuchen Yang, Li Wang, Ivonne Peugnet-González, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions
Nicholas Colangelo, Naamit K. Gerber, Ralph E. Vatner, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Small molecule induced STING degradation facilitated by the HECT ligase HERC4
Merve Mutlu, Isabel Schmidt, Andrew I. Morrison, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
A Responsive Cocktail Nano-strategy Breaking the Immune Excluded State Enhances Immunotherapy of Triple Negative Breast Cancer
Jingxian Yang, Mengyao Chen, Ruihao Li, et al.
Nanoscale (2025)
Closed Access
Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes Statuses
Alina Drzyzga, Justyna Czapla, Sybilla Matuszczak, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 175-175
Open Access
Multifaceted roles of STING in tumors: from molecular mechanisms to therapeutic strategies
Aashiq Hussain, Linchun Wen, Rui Wang
Frontiers in Chemical Biology (2025) Vol. 4
Open Access
Neoantigen vaccines: advancing personalized cancer immunotherapy
Alaa A. A. Aljabali, Yassmen Hamzat, Alaa Alqudah, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
Combination of STING agonist with anti-vascular RGD-(KLAKLAK)2 peptide as a novel anti-tumor therapy
Justyna Czapla, Alina Drzyzga, Joanna Ciepła, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 4
Author response: The common TMEM173 HAQ, AQ alleles rescue CD4 T cellpenia, restore T-regs, and prevent SAVI (N153S) inflammatory disease in mice
Alexandra Aybar-Torres, Lennon A Saldarriaga, Ann Pham, et al.
(2024)
Open Access | Times Cited: 4
Schisandrin C enhances type I IFN response activation to reduce tumor growth and sensitize chemotherapy through antitumor immunity
Huijie Yang, Xiaoyan Zhan, Zhao Jia, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Synthesis and structure-activity evaluation of a series of novel tricyclic STING activators
Sourav Basu, Sandip Middya, Ritesh Shrivastava, et al.
European Journal of Medicinal Chemistry (2025), pp. 117577-117577
Closed Access
Exogenous non-coding dsDNA-dependent trans-activation of phagocytes augments anti-tumor immunity
Tiphaine Delaunay, Sehee Son, Seongji Park, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101528-101528
Open Access | Times Cited: 3
Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy
Haider Al‐Janabi, K. Moyes, Richard Allen, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009368-e009368
Open Access | Times Cited: 3
Targeting Innate Immunity in Glioma Therapy
Andrew G. Gillard, Dong Ho Shin, Lethan A Hampton, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 947-947
Open Access | Times Cited: 2
Biomaterial‐Based Therapeutic Delivery of Immune Cells
Ameya A. Dravid, Ankur Singh, Andrés J. Garcı́a
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 2
Recent advancements in cGAS-STING activation, tumor immune evasion, and therapeutic implications
Md Saiful Islam, Mohammad Saiful Islam, Mst Rubaiat Nazneen Akhand, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top